477 related articles for article (PubMed ID: 12717200)
21. Does lamivudine prophylaxis eradicate persistent HBV DNA from allografts derived from anti-HBc-positive donors?
Loss GE; Mason AL; Nair S; Blazek J; Farr G; Guo L; Cohen AJ; Eason JD
Liver Transpl; 2003 Dec; 9(12):1258-64. PubMed ID: 14625825
[TBL] [Abstract][Full Text] [Related]
22. De novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
Xi ZF; Xia Q; Zhang JJ; Chen XS; Han LZ; Zhu JJ; Wang SY; Qiu DK
J Dig Dis; 2013 Aug; 14(8):439-45. PubMed ID: 23638710
[TBL] [Abstract][Full Text] [Related]
23. Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation.
Yu S; Yu J; Zhang W; Cheng L; Ye Y; Geng L; Yu Z; Yan S; Wu L; Wang W; Zheng S
J Hepatol; 2014 Oct; 61(4):809-15. PubMed ID: 24824283
[TBL] [Abstract][Full Text] [Related]
24. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
[TBL] [Abstract][Full Text] [Related]
25. Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature.
Loggi E; Conti F; Cucchetti A; Ercolani G; Pinna AD; Andreone P
World J Gastroenterol; 2016 Sep; 22(35):8010-6. PubMed ID: 27672295
[TBL] [Abstract][Full Text] [Related]
26. Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis.
Wong TC; Fung JY; Cui TY; Lam AH; Dai JW; Chan AC; Cheung TT; Chok KS; Ng KK; Lo CM
J Hepatol; 2019 Jun; 70(6):1114-1122. PubMed ID: 30871981
[TBL] [Abstract][Full Text] [Related]
27. Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis.
Cheung CK; Lo CM; Man K; Lau GK
Liver Transpl; 2010 Nov; 16(11):1314-23. PubMed ID: 21031547
[TBL] [Abstract][Full Text] [Related]
28. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
[TBL] [Abstract][Full Text] [Related]
29. Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors.
Chen YS; Wang CC; de Villa VH; Wang SH; Cheng YF; Huang TL; Jawan B; Chiu KW; Chen CL
Clin Transplant; 2002 Dec; 16(6):405-9. PubMed ID: 12437618
[TBL] [Abstract][Full Text] [Related]
30. Liver transplantation in hepatitis B core-negative recipients using livers from hepatitis B core-positive donors: a 13-year experience.
Bohorquez HE; Cohen AJ; Girgrah N; Bruce DS; Carmody IC; Joshi S; Reichman TW; Therapondos G; Mason AL; Loss GE
Liver Transpl; 2013 Jun; 19(6):611-8. PubMed ID: 23526668
[TBL] [Abstract][Full Text] [Related]
31. De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers.
Lee S; Kim JM; Choi GS; Park JB; Kwon CH; Choe YH; Joh JW; Lee SK
Liver Transpl; 2016 Feb; 22(2):247-51. PubMed ID: 26600319
[TBL] [Abstract][Full Text] [Related]
32. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
[TBL] [Abstract][Full Text] [Related]
33. Use of hepatitis B core antibody-positive donors for liver transplantation.
Muñoz SJ
Liver Transpl; 2002 Oct; 8(10 Suppl 1):S82-7. PubMed ID: 12362304
[TBL] [Abstract][Full Text] [Related]
34. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.
Yu L; Koepsell T; Manhart L; Ioannou G
Liver Transpl; 2009 Oct; 15(10):1343-50. PubMed ID: 19790164
[TBL] [Abstract][Full Text] [Related]
35. [Hepatitis B infection transmission by anti-HBc-positive grafts].
Bárcena R
Gastroenterol Hepatol; 2014 Jul; 37 Suppl 2():43-50. PubMed ID: 25087711
[TBL] [Abstract][Full Text] [Related]
36. Lamivudine prophylaxis for hepatitis B virus infection after lung transplantation.
Shitrit AB; Kramer MR; Bakal I; Morali G; Ben Ari Z; Shitrit D
Ann Thorac Surg; 2006 May; 81(5):1851-2. PubMed ID: 16631684
[TBL] [Abstract][Full Text] [Related]
37. Utilization of hepatitis B core antibody positive grafts in living donor liver transplantation.
Udayakumar VP; Surendran S; Padma UD
Indian J Gastroenterol; 2018 Jan; 37(1):39-43. PubMed ID: 29450703
[TBL] [Abstract][Full Text] [Related]
38. Inferior graft survival of hepatitis B core positive grafts is not influenced by post-transplant hepatitis B infection in liver recipients--5-year single-center experience.
Brandl A; Stolzlechner P; Eschertzhuber S; Aigner F; Weiss S; Vogel W; Krannich A; Neururer S; Pratschke J; Graziadei I; Öllinger R
Transpl Int; 2016 Apr; 29(4):471-82. PubMed ID: 26716608
[TBL] [Abstract][Full Text] [Related]
39. Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage?
Brock GN; Mostajabi F; Ferguson N; Carrubba CJ; Eng M; Buell JF; Marvin MR
Transpl Int; 2011 Jun; 24(6):570-81. PubMed ID: 21401727
[TBL] [Abstract][Full Text] [Related]
40. Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation.
Karasu Z; Ozacar T; Akyildiz M; Demirbas T; Arikan C; Kobat A; Akarca U; Ersoz G; Gunsar F; Batur Y; Kilic M; Tokat Y
Antivir Ther; 2004 Dec; 9(6):921-7. PubMed ID: 15651751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
